Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic.

导出 OA

翻译打印收藏纠错

第一作者： Doran,Ksienski

第一单位： BC Cancer-Victoria, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada. dksienski@bccancer.bc.ca.

作者： Doran,Ksienski ^[1] ; Sapna,Gupta ^[2] ; Pauline T,Truong ^[3] ; Jeffrey,Bone ^[3] ; Angela,Chan ^[4] ; Deepu,Alex ^[5] ; Jason,Hart ^[4] ; Philip,Pollock ^[6] ; Tiffany,Patterson ^[7] ; Melissa,Clarkson ^[3] ; Dushanthi,Dissanayake ^[4] ; Eric,Sonke ^[3] ; Mary,Lesperance ^[3]

作者单位： BC Cancer-Victoria, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada. dksienski@bccancer.bc.ca. ^[1] University of British Columbia, Victoria, BC, Canada. dksienski@bccancer.bc.ca. ^[2] BC Cancer-Victoria, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada. ^[3] University of British Columbia, Victoria, BC, Canada. ^[4] BC Children's Hospital Research Institute, Vancouver, BC, Canada. ^[5] BC Cancer-Surrey, Surrey, BC, Canada. ^[6] BC Cancer-Vancouver, Vancouver, BC, Canada. ^[7] Faculty of Medicine, University of British Columbia, Victoria, BC, Canada. ^[8] Department of Internal Medicine, University of British Columbia, Victoria, BC, Canada. ^[9] Department of Mathematics and Statistics, University of Victoria, Victoria, BC, Canada. ^[10]

关键词 COVID-19 Lung cancer Pembrolizumab Safety Toxicity

主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);疾病大流行(Pandemics);回顾性研究(Retrospective Studies)

DOI 10.1007/s00432-022-04181-0

PMID 35834010

发布时间 2023-07-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交